MedTrace Logo

Observational Study of SIROPSEDAL in Acute Cough

NCT07625683 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2026-06-04

No results posted yet for this study

Summary

This prospective, multicenter, observational post-market clinical follow-up study evaluates the performance and safety of SIROPSEDAL in children and adults with acute cough treated in routine clinical practice. Patients prescribed SIROPSEDAL independently of study participation will be followed for 7 +/- 1 days using patient-reported outcomes including a cough visual analog scale and the Cough Symptom Score.

Conditions

Sponsors & Collaborators

  • Clin-Experts

    collaborator INDUSTRY

  • Laboratoires Elerte

    lead INDUSTRY

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-15
Primary Completion
2027-05-31
Completion
2027-09-30

Countries

  • France

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07625683 on ClinicalTrials.gov